Your account is not claimed yet. You can sign up with ORCID to claim your account.

Daniel D De Carvalho

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Nature medicine

Nature cancer

Nature protocols

Nature reviews. Cancer

University of Toronto

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Toronto Jul 1o 2012

Canada

Associate Professor :: Medical Biophysics

Publications

Fabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, Ilias Ettayebi, Helen Loo Yau, Tiago Silva Medina, Sajid A Marhon, Felipe Campos de Almeida, Thiago Mantello Bianco, Andrea G F Arruda, Rebecca Devlin, Lorena Lobo de Figueiredo-Pontes, Fernando Chahud, Maira da Costa Cacemiro, Mark D Minden, Vikas K Gupta, Daniel D De Carvalho
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia. British journal of haematology (2023)
Jessica M Salmon, Izabela Todorovski, Kym L Stanley, Claudia Bruedigam, Conor J Kearney, Luciano G Martelotto, Fernando J Rossello, Timothy Semple, Gisela Mir Arnau, Magnus Zethoven, Michael Bots, Stefan Bjelosevic, Leonie A Cluse, Peter J Fraser, Veronique Litalien, Eva Vidacs, Kate McArthur, Antony Y Matthews, Elise Gressier, Nicole A de Weerd, Jens Lichte, Madison J Kelly, Simon J Hogg, Paul J Hertzog, Lev M Kats, Stephin J Vervoort, Daniel D De Carvalho, Stefanie Scheu, Sammy Bedoui, Benjamin T Kile, Steven W Lane, Andrew Charles Perkins, Andrew H Wei, Pilar M Dominguez, Ricky W Johnstone
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML. Cancer discovery 12 (6) (2022)
Parinaz Mehdipour, Raymond Chen, Daniel D De Carvalho
The next generation of DNMT inhibitors. Nature cancer 2 (10) (2022)
Shengrui Feng, Daniel D De Carvalho
Clinical advances in targeting epigenetics for cancer therapy. The FEBS journal (2021)
Justin M Burgener, Jinfeng Zou, Zhen Zhao, Yangqiao Zheng, Shu Yi Shen, Shao Hui Huang, Sareh Keshavarzi, Wei Xu, Fei-Fei Liu, Geoffrey Liu, John N Waldron, Ilan Weinreb, Anna Spreafico, Lillian L Siu, John R de Almeida, David P Goldstein, Michael M Hoffman, Daniel D De Carvalho, Scott V Bratman
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Sujun Chen, Guanghui Zhu, Yue Yang, Fu-Bo Wang, Yu-Tian Xiao, Na Zhang, Xiaojie Bian, Yasheng Zhu, Yongwei Yu, Fei Liu, Keqin Dong, Javier Mariscal, Yin Liu, Fraser Soares, Helen Loo Yau, Bo Zhang, Weidong Chen, Chao Wang, Dai Chen, Qinghua Guo, Zhengfang Yi, Mingyao Liu, Michael Fraser, Daniel D De Carvalho, Paul C Boutros, Dolores Di Vizio, Zhou Jiang, Theodorus H Van der Kwast, Alejandro Berlin, Song Wu, Jianhua Wang, Housheng Hansen He, Shancheng Ren
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nature cell biology 23 (1) (2021)
Elvin Wagenblast, Joana Araújo, Olga I Gan, Sarah K Cutting, Alex Murison, Gabriela Krivdova, Maria Azkanaz, Jessica L McLeod, Sabrina A Smith, Blaise A Gratton, Sajid A Marhon, Martino Gabra, Jessie J F Medeiros, Sanaz Manteghi, Jian Chen, Michelle Chan-Seng-Yue, Laura Garcia-Prat, Leonardo Salmena, Daniel D De Carvalho, Sagi Abelson, Mohamed Abdelhaleem, Karen Chong, Maian Roifman, Patrick Shannon, Jean C Y Wang, Johann K Hitzler, David Chitayat, John E Dick, Eric R Lechman
Mapping the cellular origin and early evolution of leukemia in Down syndrome. Science (New York, N.Y.) 373 (6551) (2021)
Kirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, Ben Wang, Shu Yi Shen, Ilias Ettayebi, Charles A Ishak, Philippe L Bedard, Albiruni Abdul Razak, Aaron R Hansen, Anna Spreafico, Dave Cescon, Marcus O Butler, Amit M Oza, Stephanie Lheureux, Neda Stjepanovic, Brendan Van As, Sarah Boross-Harmer, Lisa Wang, Trevor J Pugh, Pamela S Ohashi, Lillian L Siu, Daniel D De Carvalho
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Journal for immunotherapy of cancer 8 (2) (2021)
Parinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, Ankur Chakravarthy, Amir Hosseini, Yadong Wang, Fabíola Attié de Castro, Helen Loo Yau, Charles Ishak, Sagi Abelson, Catherine A O'Brien, Daniel D De Carvalho
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency. Nature 588 (7836) (2020)
Marie Jo Halaby, Kebria Hezaveh, Sara Lamorte, M Teresa Ciudad, Andreas Kloetgen, Bethany L MacLeod, Mengdi Guo, Ankur Chakravarthy, Tiago da Silva Medina, Stefano Ugel, Aristotelis Tsirigos, Vincenzo Bronte, David H Munn, Trevor J Pugh, Daniel D De Carvalho, Marcus O Butler, Pamela S Ohashi, David G Brooks, Tracy L McGaha
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment. Science immunology 4 (42) (2020)
Farshad Nassiri, Ankur Chakravarthy, Shengrui Feng, Shu Yi Shen, Romina Nejad, Jeffrey A Zuccato, Mathew R Voisin, Vikas Patil, Craig Horbinski, Kenneth Aldape, Gelareh Zadeh, Daniel D De Carvalho
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes. Nature medicine 26 (7) (2020)
Pier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, Sandor Spisak, Amin H Nassar, Sarah Abou Alaiwi, Ankur Chakravarthy, Shu Yi Shen, Ziad Bakouny, Francesco Boccardo, John Steinharter, Gabrielle Bouchard, Catherine R Curran, Wenting Pan, Sylvan C Baca, Ji-Heui Seo, Gwo-Shu Mary Lee, M Dror Michaelson, Steven L Chang, Sushrut S Waikar, Guru Sonpavde, Rafael A Irizarry, Mark Pomerantz, Daniel D De Carvalho, Toni K Choueiri, Matthew L Freedman
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. Nature medicine 26 (7) (2020)
Shu Yi Shen, Justin M Burgener, Scott V Bratman, Daniel D De Carvalho
Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA. Nature protocols 14 (10) (2019)
Peter A Jones, Hitoshi Ohtani, Ankur Chakravarthy, Daniel D De Carvalho
Epigenetic therapy in immune-oncology. Nature reviews. Cancer 19 (3) (2019)

Daniel D De Carvalho.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel D De Carvalho